Effects of formoterol and ipratropium bromide on repeated cadmium inhalation-induced pulmonary inflammation and emphysema in rats

European Journal of Pharmacology

Volumn 647, Issue 1-3, 2010, Pages 178-187

  Zhang, WenHui ^a   Fievez, Laurence ^b   Zhang, Fan ^a   Cheu, Esteban ^b   Antoine, Nadine ^b   Delguste, Catherine ^b   Zhang, Yong ^a   Rong, WeiFang ^a   Bureau, Fabrice ^b   Advenier, Charles ^c   Gustin, Pascal ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UPRES EA 220   (France)

Author keywords

Airspace enlargement; Cadmium; Chronic pulmonary inflammation; Formoterol; Ipratropium bromide; Matrix metalloproteinase

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CADMIUM; CHOLINERGIC RECEPTOR; FORMOTEROL; GELATINASE A; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; IPRATROPIUM BROMIDE; MACROPHAGE ELASTASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CHRONIC INFLAMMATION; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; EMPHYSEMA; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; INFLAMMATORY INFILTRATE; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS WALL; LUNG EMPHYSEMA; LUNG INJURY; LUNG INTERSTITIUM; LUNG LAVAGE; MALE; MONOTHERAPY; NEUTROPHIL COUNT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPEAT PROCEDURE;

EID: 77957307358     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.08.028     Document Type: Article

References (46)

1. Aaron S.D., Vandemheen K.L., Fergusson D., Maltais F., Bourbeau J., Goldstein R., Balter M., O'Donnell D., McIvor A., Sharma S., Bishop G., Anthony J., Cowie R., Field S., Hirsch A., Hernandez P., Rivington R., Road J., Hoffstein V., Hodder R., Marciniuk D., McCormack D., Fox G., Cox G., Prins H.B., Ford G., Bleskie D., Doucette S., Mayers I., Chapman K., Zamel N., FitzGerald M. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 2007, 146:545-555.
2. Abboud R.T., Vimalanathan S. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int. J. Tuberc. Lung Dis. 2008, 12:361-367.
3. Abraham G., Kottke C., Dhein S., Ungemach F.R. Agonist-independent alteration in beta-adrenoceptor-G-protein-adenylate cyclase system in an equine model of recurrent airway obstruction. Pulm. Pharmacol. Ther. 2006, 19:218-229.
4. Asano K., Shikama Y., Shibuya Y., Nakajima H., Kanai K., Yamada N., Suzaki H. Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro. Int J Chron Obstruct Pulmon Dis 2008, 3:781-789.
5. Barnes P.J. Mediators of chronic obstructive pulmonary disease. Pharmacol. Rev. 2004, 56:515-548.
6. Bos I.S., Gosens R., Zuidhof A.B., Schaafsma D., Halayko A.J., Meurs H., Zaagsma J. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur. Respir. J. 2007, 30:653-661.
7. Cazzola M., Dahl R. Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD. Chest 2004, 126:220-237.
8. Chen Y., Hanaoka M., Chen P., Droma Y., Voelkel N.F., Kubo K. Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296:L648-656.
9. Churg A., Wang R., Wang X., Onnervik P.O., Thim K., Wright J.L. Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax 2007, 62:706-713.
10. Corbel M., Boichot E., Lagente V. Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz. J. Med. Biol. Res. 2000, 33:749-754.
11. D'Hulst A.I., Vermaelen K.Y., Brusselle G.G., Joos G.F., Pauwels R.A. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur. Respir. J. 2005, 26:204-213.
12. Demedts I.K., Brusselle G.G., Bracke K.R., Vermaelen K.Y., Pauwels R.A. Matrix metalloproteinases in asthma and COPD. Curr. Opin. Pharmacol. 2005, 5:257-263.
13. Fievez L., Kirschvink N., Belleflamme M., Lagente V., Gustin P. Effects of the MMP inhibitor GM-6001 on emphysema development, inflammation and MMPs activity induced by cadmium in rats. Fundam. Clin. Pharmacol. 2006, 20:194.
14. Gosens R., Zaagsma J., Meurs H., Halayko A.J. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir. Res. 2006, 7:73.
15. Hanania N.A., Donohue J.F. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators. Proc. Am. Thorac Soc. 2007, 4:526-534.
16. Hanania N.A., Moore R.H. Anti-inflammatory activities of beta2-agonists. Curr. Drug Targets Inflamm. Allergy 2004, 3:271-277.
17. Hoidal J.R., Niewoehner D.E., Rao N.V., Hibbs M.S. The role of neutrophils in the development of cadmium chloride-induced emphysema in lathyrogen-fed hamsters. Am. J. Pathol. 1985, 120:22-29.
18. Johnson M. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J. Allergy Clin. Immunol. 2006, 117:18-24 quiz 25.
19. Jones P.W. Triple therapy for chronic obstructive pulmonary disease: trials catching up with clinical practice?. Am. J. Respir. Crit. Care Med. 2009, 180:689-690.
20. Kim J.H., Suk M.H., Yoon D.W., Lee S.H., Hur G.Y., Jung K.H., Jeong H.C., Lee S.Y., Suh I.B., Shin C., Shim J.J., In K.H., Yoo S.H., Kang K.H. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L580-587.
21. Kirschvink N., Leemans J., Delvaux F., Snaps F., Clercx C., Gustin P. Non-invasive assessment of airway responsiveness in healthy and allergen-sensitised cats by use of barometric whole body plethysmography. Vet. J. 2007, 173:343-352.
22. Kirschvink N., Vincke G., Fievez L., Onclinx C., Wirth D., Belleflamme M., Louis R., Cataldo D., Peck M.J., Gustin P. Repeated cadmium nebulizations induce pulmonary MMP-2 and MMP-9 production and emphysema in rats. Toxicology 2005, 211:36-48.
23. Lagente V., Manoury B., Nenan S., Le Quement C., Martin-Chouly C., Boichot E. Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz. J. Med. Biol. Res. 2005, 38:1521-1530.
24. Li W., Li J., Wu Y., Wu J., Hotchandani R., Cunningham K., McFadyen I., Bard J., Morgan P., Schlerman F., Xu X., Tam S., Goldman S.J., Williams C., Sypek J., Mansour T.S. A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b, d]furan-3-sulfonamido)-3-methylbu tanoic acid (MMP408). J. Med. Chem. 2009, 52:1799-1802.
25. Ma S., Lin Y.Y., Tartell L., Turino G.M. The effect of tiotropium therapy on markers of elastin degradation in COPD. Respir. Res. 2009, 10:12.
26. Mannino D.M., Holguin F., Greves H.M., Savage-Brown A., Stock A.L., Jones R.L. Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey. Thorax 2004, 59:194-198.
27. McQueen D.S., Donaldson K., Bond S.M., McNeilly J.D., Newman S., Barton N.J., Duffin R. Bilateral vagotomy or atropine pre-treatment reduces experimental diesel-soot induced lung inflammation. Toxicol. Appl. Pharmacol. 2007, 219:62-71.
28. Miyamoto M., Tomaki M., Lotvall J., Linden A. Beta-adrenoceptor stimulation and neutrophil accumulation in mouse airways. Eur. Respir. J. 2004, 24:231-237.
29. Molfino N.A., Jeffery P.K. Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies. Pulm. Pharmacol. Ther. 2007, 20:462-472.
30. Mori H., Nose T., Ishitani K., Kasagi S., Souma S., Akiyoshi T., Kodama Y., Mori T., Kondo M., Sasaki S., Iwase A., Takahashi K., Fukuchi Y., Seyama K. Phosphodiesterase 4 inhibitor GPD-1116 markedly attenuates the development of cigarette smoke-induced emphysema in senescence-accelerated mice P1 strain. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L196-204.
31. Mortaz E., Rad M.V., Johnson M., Raats D., Nijkamp F.P., Folkerts G. Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke. J. Mol. Med. 2008, 86:1045-1056.
32. Nakanishi Y., Kobayashi D., Asano Y., Sakurai T., Kashimura M., Okuyama S., Yoneda Y., Shapiro S.D., Takayama K. Clarithromycin prevents smoke-induced emphysema in mice. Am. J. Respir. Crit. Care Med. 2009, 179:271-278.
33. Nenan S., Lagente V., Planquois J.M., Hitier S., Berna P., Bertrand C.P., Boichot E. Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat. Eur. J. Pharmacol. 2007, 559:75-81.
34. O'Kane C.M., McKeown S.W., Perkins G.D., Bassford C.R., Gao F., Thickett D.R., McAuley D.F. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit. Care Med. 2009, 37:2242-2249.
35. Parameswaran H., Majumdar A., Ito S., Alencar A.M., Suki B. Quantitative characterization of airspace enlargement in emphysema. J. Appl. Physiol. 2006, 100:186-193.
36. Patiyal S.N., Katoch S.S. Beta-adrenoceptor agonist clenbuterol down-regulates matrix metalloproteinase (MMP-9) and results in an impairment of collagen turnover in mice left ventricle. Jpn J. Physiol. 2005, 55:165-172.
37. Powrie D.J., Wilkinson T.M., Donaldson G.C., Jones P., Scrine K., Viel K., Kesten S., Wedzicha J.A. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur. Respir. J. 2007, 30:472-478.
38. Profita M., Giorgi R.D., Sala A., Bonanno A., Riccobono L., Mirabella F., Gjomarkaj M., Bonsignore G., Bousquet J., Vignola A.M. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005, 60:1361-1369.
39. Razani-Boroujerdi S., Behl M., Hahn F.F., Pena-Philippides J.C., Hutt J., Sopori M.L. Role of muscarinic receptors in the regulation of immune and inflammatory responses. J. Neuroimmunol. 2008, 194:83-88.
40. Russell R.E., Culpitt S.V., DeMatos C., Donnelly L., Smith M., Wiggins J., Barnes P.J. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2002, 26:602-609.
41. Selman M., Cisneros-Lira J., Gaxiola M., Ramirez R., Kudlacz E.M., Mitchell P.G., Pardo A. Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in Guinea pigs. Chest 2003, 123:1633-1641.
42. Thurlbeck W. Internal surface area and other measurements in emphysema. Thorax 1967, 22:483-496.
43. Welte T., Miravitlles M., Hernandez P., Eriksson G., Peterson S., Polanowski T., Kessler R. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2009, 180:741-750.
44. Whelan C.J., Johnson M., Vardey C.J. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br. J. Pharmacol. 1993, 110:613-618.
45. Zhang W., Fievez L., Cheu E., Bureau F., Rong W., Zhang F., Zhang Y., Advenier C., Gustin P. Anti-inflammatory effects of formoterol and ipratropium bromide against acute cadmium-induced pulmonary inflammation in rats. Eur. J. Pharmacol. 2010, 628:171-178.
46. Zhu W.J., He B., Xu M. Expression and significance of beta(2)-adrenoreceptor in inflammatory cells of patients with chronic obstructive pulmonary disease. Zhonghua Yi Xue Za Zhi 2008, 88:2099-2102.